Traduction de «état postopératoire avec implantation » (Français → Anglais) :

active implantable medical devices covered by Council Directive 90/385/EEC of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices

Sampling points targeted at the protection of vegetation and natural ecosystems shall be sited more than 20 km away from agglomerations or more than 5 km away from other built-up areas, industrial installations or motorways or major roads with traffic counts of more than 50 000 vehicles per day, which means that a sampling point must be sited in such a way that the air sampled is representative of air quality in a surrounding area of at least 1 000 km. A Member State may provide for a sampling point to be sited at a lesser distance or to be representative of air quality in a less extended area, taking account of geographical conditions o ...[+++]r of the opportunities to protect particularly vulnerable areas.

The talks between Canada and the United States concerning Canada's possible participation in the U.S.-planned ballistic missile defence system have been underway for several months with no information coming forth to enable the Canadian people to understand what is going on.

Today the implant chip is also used on pets in the U.S. Oracle is ready to provide the government with the technology for free.

[Text] Question No. 104 Mr. Rob Merrifield: With regard to the health impacts on Canadians of breast implants: (a) will the government offer financial compensation for victims of faulty breast implants and, if yes, when will this be available; (b) when will Health Canada release the results of its breast implant cohort study launched in 1996 and promised by the end of 2000; (c) why has this study not yet been released; (d) will the government consider establishing a national registry to track the health status, including adverse effects, of recipients of breast implants; (e) will the government consider establishing a national breast ...[+++] implant user registry to tally the health care costs associated with breast implant users; (f) is Health Canada in possession of information estimating the health care costs associated with breast implant recipients; (g) what is Health Canada currently doing to ensure the safety and efficacy of both silicone and saline implants; (h) is Health Canada assured that women receiving silicone implants through the special access program are properly apprised of the associated risks; and (i) what was Health Canada's reaction to warnings over the years from its Health Protection Branch that breast implants were potentially dangerous?

(5) The measures provided for in this Directive are in accordance with the opinion of the Committee on Medical Devices set up by Article 6(2) of Council Directive 90/385/EEC of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices(3), as last amended by Directive 93/68/EEC(4),